CELEX: 32020M9967
Language: en
Date: 2020-10-29 00:00:00
Title: Commission Decision of 29/10/2020 declaring a concentration to be compatible with the common market (Case No COMP/M.9967 - KOHLBERG / MUBADALA / PARTNERS GROUP / PIONEER UK MIDCO 1) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels, 29.10.2020
                                                                C(2020) 7617 final
                                                                                 PUBLIC VERSION
                                                                To the notifying parties
Subject:        Case M.9967 – KOHLBERG / MUBADALA / PARTNERS GROUP /
                PIONEER UK MIDCO 1
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 1 October 2020, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which the
        undertakings Kolhberg & Co L.L.C. (U.S.A.), Mubadala Investment Company PJSC
        (U.A.E.) and Partners Group AG (Switzerland) acquire within the meaning of Article
        3(1)(b) and Article 3(4) of the Merger Regulation joint control of the whole of Pioneer
        UK Midco 1 Limited (U.K.) and its subsidiary PCI Pharma Services. The
        concentration is accomplished by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             Kohlberg & Co., L.L.C.: a U.S. private equity management company specialised
              in investments in middle market companies, with a portfolio of companies active
              in various industries, such as industrial manufacturing, consumer products,
              business services, healthcare services and financial services,
             Mubadala Investment Company PJSC: an Emirati public joint stock company
              focused on investment and development across a number of industries, including
              aerospace, ICT, semiconductors, metals and mining, renewable energy, oil and
              gas, petrochemicals, utilities, healthcare, real estate, pharma and medtech,
              agribusiness and it has a global portfolio of financial holdings,
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 335, 09.10.2020, p. 9.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---        Partners Group AG: a Swiss private markets investment management company
        operating globally in the areas of private equity, private real estate, private
        infrastructure and private debt,
       Pioneer UK Midco 1 Limited: a U.K. holding company which owns and controls
        the group of companies doing business as PCI, the latter being a global provider
        of services to the pharmaceutical and biotech industries in clinical trial services,
        commercial packaging and development and manufacturing of pharmaceuticals.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                  For the Commission
                                                  (Signed)
                                                  Olivier GUERSENT
                                                  Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                              2